​

IO Biotech (IOBT) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

IOBT Stock Forecast

IO Biotech (IOBT) stock forecast, based on 6 Wall Street analysts, predicts a 12-month average price target of $0.50, with a high of $0.50 and a low of $0.50. This represents a 38.89% increase from the last price of $0.36.

High: $0.5 Avg: $0.5 Low: $0.5 Last Closed Price: $0.36

IOBT Stock Rating

IO Biotech stock's rating consensus is Buy, based on 6 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (50.00%), 3 Hold (50.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 6 0 3 3 Strong Sell Sell Hold Buy Strong Buy

IOBT Price Target Upside V Benchmarks

TypeNameUpside
StockIO Biotech38.89%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts112
Avg Price Target$0.50$0.50$1.75
Last Closing Price$0.36$0.36$0.36
Upside/Downside38.89%38.89%386.11%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 26-121-4
Jan, 26113--5
Dec, 25113--5
Nov, 25113--5
Oct, 25113--5
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jan 26, 2026Piper Sandler$0.50$0.3735.14%38.89%
Oct 22, 2025Piper Sandler$3.00$1.02194.12%733.33%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jan 23, 2026Piper SandlerOverweightNeutraldowngrade
Jan 08, 2026Morgan StanleyOverweightUnderweightdowngrade
Sep 30, 2025Cowen & Co.Holddowngrade
Sep 29, 2025H.C. WainwrightBuyNeutraldowngrade
May 14, 2025H.C. WainwrightBuyBuyhold
Sep 16, 2024Morgan StanleyOverweightOverweighthold
Sep 03, 2024JefferiesBuyBuyhold
Sep 03, 2024Piper SandlerOverweightOverweighthold
Sep 03, 2024H.C. WainwrightBuyBuyhold
Dec 03, 2021Morgan StanleyOverweightinitialise

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.98$-1.45----
Avg Forecast$-1.96$-1.36$-1.33$-1.18$-0.68$-0.13
High Forecast$-1.85$-1.31$-1.04$-1.00$-0.59$-0.13
Low Forecast$-2.07$-1.42$-1.52$-1.45$-0.82$-0.13
Surprise %1.02%6.62%----

Revenue Forecast

$0 $40M $80M $120M $160M $200M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast--$940.00K$26.60M$74.50M$196.11M
High Forecast--$940.00K$26.60M$78.01M$196.11M
Low Forecast--$940.00K$26.60M$70.99M$196.11M
Surprise %------

Net Income Forecast

$-100M $-81M $-62M $-43M $-24M $-5M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-86.08M$-95.49M----
Avg Forecast$-86.08M$-59.35M$-55.66M$-53.35M$-30.70M$-5.66M
High Forecast$-80.43M$-56.94M$-45.32M$-43.43M$-25.69M$-5.66M
Low Forecast$-90.33M$-61.76M$-66.00M$-63.26M$-35.70M$-5.66M
Surprise %-60.90%----

IOBT Forecast FAQ

Is IO Biotech stock a buy?

IO Biotech stock has a consensus rating of Buy, based on 6 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that IO Biotech is a favorable investment for most analysts.

What is IO Biotech's price target?

IO Biotech's price target, set by 6 Wall Street analysts, averages $0.5 over the next 12 months. The price target range spans from $0.5 at the low end to $0.5 at the high end, suggesting a potential 38.89% change from the previous closing price of $0.36.

How does IO Biotech stock forecast compare to its benchmarks?

IO Biotech's stock forecast shows a 38.89% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for IO Biotech over the past three months?

  • February 2026: 0% Strong Buy, 25.00% Buy, 50.00% Hold, 25.00% Sell, 0% Strong Sell.
  • January 2026: 20.00% Strong Buy, 20.00% Buy, 60.00% Hold, 0% Sell, 0% Strong Sell.
  • December 2025: 20.00% Strong Buy, 20.00% Buy, 60.00% Hold, 0% Sell, 0% Strong Sell.

What is IO Biotech’s EPS forecast?

IO Biotech's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.33, marking a -8.28% decrease from the reported $-1.45 in 2024. Estimates for the following years are $-1.18 in 2026, $-0.68 in 2027, and $-0.13 in 2028.

What is IO Biotech’s revenue forecast?

IO Biotech's average annual revenue forecast for its fiscal year ending in December 2025 is $940K, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $26.6M, followed by $74.5M for 2027, and $196.11M for 2028.

What is IO Biotech’s net income forecast?

IO Biotech's net income forecast for the fiscal year ending in December 2025 stands at $-55.662M, representing a -41.71% decrease from the reported $-95.491M in 2024. Projections indicate $-53.345M in 2026, $-30.696M in 2027, and $-5.66M in 2028.